Ship Healthcare : Summary of Financial Statements for Fiscal Year Ended March 31 , 2021(Consolidated)

Summary of Financial Statements

for Fiscal Year Ended March 31, 2021 [Japanese GAAP]

(Consolidated)

May 11, 2021

Name of listed company:	SHIP HEALTHCARE HOLDINGS, INC.
	Shares listed on: Tokyo Stock Exchange
Code:	3360	URL https://www.shiphd.co.jp/

Representative:	(Title) Chairman and CEO	(Name) Kunihisa Furukawa
Contact:	(Title) Executive Director	(Name) Hiroshi Yokoyama
		Tel.: [phone]

Scheduled date for regular general meeting of shareholders: June 29, 2021

Scheduled start date for dividend payments: June 30, 2021

Scheduled date for filing securities report: June 29, 2021

Supplementary briefing materials on results: Y

Briefing on results: Y (for institutional investors and analysts)

(All figures are rounded down to the nearest millions yen.)

1. Consolidated financial results for the fiscal year ended March 31, 2021 (April 1, 2020 - March 31, 2021)

(1) Consolidated operating results				(Percentages represent year-on-year changes.)
	Net sales		Operating profit	Ordinary profit		Profit attributable to
			owners of parent
	(Millions yen)		%	(Millions yen)	%	(Millions yen)		%	(Millions yen)		%
FY ended March 2021	497,156		2.6	21,800	16.0	21,761		9.2	12,280		4.0
FY ended March 2020	484,395		9.1	18,794	4.7	19,931		7.6	11,803		5.0

Note: Comprehensive income: FY ended March 2021: ¥ 14,442 million (35.8 %)
		FY ended March 2020: ¥10,638 million ((8.8) %)
		Net income per	Diluted net	Return on	Return on	Operating margin
		share	income per share	equity	assets
		(Yen)	(Yen)	%	%	%
	FY ended March 2021	129.99	117.95	11.5	6.8	4.4
	FY ended March 2020	124.02	112.62	12.0	6.6	3.9

Reference: Share of profit (loss) of entities accounted for using equity method: FY ended March 31, 2021: ¥(40) million;

FY ended March 31, 2020: ¥38 million

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. "Net income per share" and "Diluted net income per share" are calculated as if the relevant stock split was executed at the beginning of the previous consolidated fiscal year ended March 31, 2020.

(2) Consolidated financial condition

	Total assets	Net assets	Equity capital ratio	Net assets per share
	(Millions yen)	(Millions yen)	%	(Yen)
FY ended March 2021	334,498	115,103	33.3	1,181.14
FY ended March 2020	308,873	104,681	33.0	1,073.35

Reference: Equity: FY ended March 2021: ¥111,440 millions yen; FY ended March 2020: ¥101,784 millions yen

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. "Net assets per share" are calculated as if the relevant stock split was executed at the beginning of the previous consolidated fiscal year ended March 31, 2020.

(3) Consolidated cash flows

	Net cash from operating	Net cash from investing	Net cash from financing	Cash and cash
	equivalents at end of
	activities	activities	activities
	period
	(Millions yen)	(Millions yen)	(Millions yen)	(Millions yen)
FY ended March 2021	19,772	(19,289)	(10,465)	72,950
FY ended March 2020	24,010	(4,264)	(8,416)	82,810

2. Dividends

		Annual dividends		Total annual	Payout ratio	Dividends to net
			assets
	End Q1	End Q2	End Q3	Year-end	Total	dividends	(consolidated)
	(consolidated)
	(Yen)	(Yen)	(Yen)	(Yen)	(Yen)	(Millions yen)	%	%
FY ended March 2020	-	0.00	-	75.00	75.00	3,556	30.2	5.9
FY ended March 2021	-	0.00	-	80.00	80.00	3,774	30.8	3.5
FY ending March 2022	-	0.00	-	41.00	41.00		30.9
(projected)

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. Annual dividends for the year ended March 31, 2020 and 2021 are actual amounts paid prior to the relevant stock split. Projected annual dividends for the year ending March 31, 2022 are the amount after the relevant stock split.

3. Forecast of consolidated financial results for the fiscal year ending March 31, 2022 (April 1, 2021 - March 31, 2022)

(Percentages represent changes from previous year.)

	Net sales		Operating profit	Ordinary profit	Profit attributable to	Net income per
		owners of parent	share
	(Millions yen)		%	(Millions yen)	%	(Millions yen)	%	(Millions yen)	%	(Yen)
Cumulative through	225,000		1.9	6,500	(17.0)	6,500	(21.4)	3,800	(19.3)	40.28
second quarter
Full-year	53,000		6.6	22,500	3.2	22,500	3.4	12,500	1.8	132.48

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. "Net income per share" in the forecast of consolidated financial results for the fiscal year ending March 31, 2022 is calculated based on the number of shares outstanding after the relevant stock split.

(Percentages represent year-on-yearchanges.)

Notes

(1)	Changes made in significant subsidiaries during consolidated cumulative quarter under review:	None
(2)	Changes made in accounting policies, accounting estimates, and/or restatements:
	(i)	Changes in accounting policies associated with changes in accounting standards, etc.:	None
	(ii)	Any changes in accounting policies other than those under (i) above:	Yes
	(iii) Changes in accounting estimates:	None
	(iv) Restatements:	None
(3)	Number of shares issued and outstanding (common stocks)

1. Number of shares issued and outstanding at the end of the period (including treasury stock)
2. Number of treasury stock at the end of the period
3. Average number of shares during the period

FY ended March	101,669,400 shares	FY ended March	101,669,400 shares
2021	2020
FY ended March	7,319,054 shares	FY ended March	6,841,254 shares
2021	2020
FY ended March	94,470,499 shares	FY ended March	95,175,182 shares
2021	2020

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. "Number of shares issued and outstanding at the end of the period", "Number of treasury stock at the end of the period", and "Average number of shares during the period" are calculated as if the relevant stock split was executed at the beginning of the previous consolidated fiscal year ended March 31, 2020.

Reference: Overview of non-consolidated financial results

1. Non-consolidated financial results for fiscal year ended March 31, 2021 (April 1, 2020-March 31, 2021)

(1) Non-consolidated operating results

	Net sales		Operating profit	Ordinary profit		Net income
	(Millions yen)		%	(Millions yen)	%	(Millions yen)		%	(Millions yen)		%
FY ended March 2021	7,657		6.5	6,377	10.6	6,214		7.4	6,137		8.8
FY ended March 2020	7,191		2.1	5,764	(2.0)	5,785		(1.2)	5,642		(1.8)
	Net income per share	Diluted net income per
	share
			(Yen)		(Yen)
FY ended March 2021			64.97		58.87
FY ended March 2020			59.28		53.75

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. "Net income per share" and "Diluted net income per share" are calculated as if the relevant stock split was executed at the beginning of the previous consolidated fiscal year ended March 31, 2020.

(2) Non-consolidated financial condition

	Total assets	Net assets	Equity capital ratio	Net assets per share
	(Millions yen)	(Millions yen)	%	(Yen)
FY ended March 2021	85,527	48,395	56.6	512.93
FY ended March 2020	80,388	45,638	56.8	481.28

Reference: Equity: FY ended March 31, 2021: ¥ 48,395 million; FY ended March 31, 2020: ¥45,638 million

Note: The company executed a two-for-one common stock split, effective on April 1, 2021. "Net assets per share" are calculated as if the relevant stock split was executed at the beginning of the previous consolidated fiscal year ended March 31, 2020.

• This summary of financial results is not subject to quarterly review by a Certified Public Accountant or an audit firm.
• Information on appropriate use of financial forecasts and other special notes:

• The forecasts of financial results and other forward-looking statements provided herein are based on information available at the time this document was prepared and certain assumptions considered reasonable. Actual results may differ significantly from forecasts due to various factors. For assumptions underlying forecasts of financial results, notes on use of forecasts of financial results, and other related information, please refer to "Future outlook" on page 4 of the Annexed Materials.
• The Company is a holding company and the bulk of its revenue consists of dividends received from subsidiaries and revenues from their operating costs. Detailed information on non-consolidated financial forecasts is omitted since information is not important for investment information and business indicators.

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for Fiscal Year Ended March 31, 2021

• Index of attached materials

1.	Qualitative information on quarterly results .....................................................................................................	2
	(1)	Description of business results ................................................................................................................	2
	(2)	Analysis of financial position ..................................................................................................................	3
	(3)	Analysis of cash flows ...........................................................................................................................	3
	(4)	Future outlook .........................................................................................................................................	4
2.	Basic approach in selecting accounting standards ............................................................................................	4
3.	Consolidated financial statements and notes thereto ........................................................................................	5
	(1)	Consolidated balance sheet ......................................................................................................................	5
	(2)	Consolidated statement of income and consolidated statement of comprehensive income .....................	7
	(3) Consolidated statements of changes in shareholders' equity ..................................................................	10
	(4) Consolidated statement of cash flows ....................................................................................................	12
	(5)	Notes on consolidated financial statements ............................................................................................	14
		(Notes on the going concern assumption)...............................................................................................	14
		(Changes in accounting policy) ..............................................................................................................	14
		(Segment information, etc.) ....................................................................................................................	14
		(Per-share information)...........................................................................................................................	19
		(Important subsequent information)........................................................................................................	20

1

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for Fiscal Year Ended March 31, 2021

1. Qualitative information on quarterly results

(1) Description of business results

In the Japanese economy during FY ended March 2021, economic and social activities have been severely restricted as the number of infected people remains high due to the expansion of the COVID-19 and its variants. Signs of business recovery remain uncertain due to the decrease in personal consumption and corporate profits.

Healthcare industry in which the Group operates, especially at the beginning of the fiscal year, the number of medical institutions whose profits declined due to the avoidance of medical consultations and a decrease in the number of operations increased. In order to meet the social demands for the treatment against COVID-19, they are required to make new capital investment such as securing personnel and preparation for the thorough measures against the infection even under the harsh business condition from above reasons, as a result, the environment in the industry continues to be in a difficult situation.

Under such economic conditions, the Group's performance generally recorded as planned thanks to the firm sales of infectious disease control products such as low-concentration ozone generators "Airness" and original brand mask made in Japan, "SHIP mask", in addition to the increase of orders for the projects related to infectious disease control in Total Pack Produce business. Also, the occupancy rate remained high by taking thorough measures against the infectious disease in Lifecare business which operates pay nursing homes.

For FY ended March 2021, the various factors noted above resulted in net sales of 497,156 million yen (up 2.6% YoY), operating profit of 21,800 million yen (up 16.0% YoY), ordinary profit of 21,761 million yen (up 9.2% YoY), and profit attributable to owners of the parent of 12,280 million yen (up 4.0% YoY).

Business results by segment are summarized below.

1. Total Pack Produce business
   In Total Pack Produce business, new initiatives such as the development and sale of infectious disease control products , temporary fever outpatients buildings, and simple negative-pressure ventilators have been successful although the conventional business performed poorly because there were more small-size projects than usual. There was some impact due to the deterioration of public security in Federal Republic of Myanmar, however, the business performed generally as planned.
   As a result, this segment recorded net sales of 99,959 million yen (down 0.7% YoY) and segment profit (operating profit) of 9,634 million yen (up 0.1% YoY).
2. Medical Supply business
   In Medical Supply business, although the business was affected by the impact from redemption price revision and the spread of COVID-19 at the beginning of the fiscal year which caused the avoidance of medical consultations and decrease in demand for medical materials, business performance remained steady by the efforts to strengthen sales of infectious disease control products, collaborate within the group, and improve in management efficiency. Also, the first automated logistic warehouse in the industry "Osaka Solution Center" has been completed.
   As a result, this segment recorded net sales of 337,244 million yen (up 3.6% YoY) and segment profit (operating profit) of 6,715 million yen (up 33.4% YoY).
3. Lifecare business
   In Lifecare business, occupancy rate maintained high along with the progress of management efficiency through nationwide integrated management and strict infectious disease control.
   As a result, this segment recorded net sales of 24,571 million yen (up 2.7% YoY) and segment profit (operating profit) of 2,237 million yen (up 26.4% YoY).
4. Dispensing Pharmacy business
   In Dispensing Pharmacy business, despite the impact of the drug price revision, business performance was firm due to improvements in management efficiency and the accumulation of small-size M&A.
   As a result, this segment recorded net sales of 27,070 million yen (up 0.1% YoY) and segment profit (operating profit) of 2,884 million yen (up 8.4% YoY)
5. Other
   In Other business, business performance of the veterinary hospital, security support company, and comprehensive building management company progressed generally as planned.
   As a result, this segment recorded net sales of 8,309 million yen (up 17.7% YoY) and segment profit (operating profit) of 591 million yen (up 31.5% YoY).

2